Russo A - Search Results

1

Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib.

Vincenzi B, Santini D, Russo A, Addeo R, Giuliani F, Montella L, Rizzo S, Venditti O, Frezza AM, Caraglia M, Colucci G, Del Prete S, Tonini G. Vincenzi B, et al. Among authors: russo a. Oncologist. 2010;15(1):85-92. doi: 10.1634/theoncologist.2009-0143. Epub 2010 Jan 5. Oncologist. 2010. PMID: 20051477 Free PMC article.

2

Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study.

Giorgio CG, Giuffrida D, Pappalardo A, Russo A, Santini D, Salice P, Blanco G, Castorina S, Failla G, Bordonaro R. Giorgio CG, et al. Among authors: russo a. Lung Cancer. 2005 Nov;50(2):247-54. doi: 10.1016/j.lungcan.2005.05.026. Epub 2005 Jul 20. Lung Cancer. 2005. PMID: 16039010 Clinical Trial.

3

Paclitaxel, carboplatin and gemcitabine combination as induction chemotherapy for stage IIIA N2 bulky non-small cell lung cancer.

Giannitto GC, Giuffrida D, Pappalardo A, Russo A, Vincenzi B, Saita S, Potenza E, Marletta F, La Venia G, Castorina S, Bordonaro R. Giannitto GC, et al. Among authors: russo a. Oncology. 2005;69(4):295-300. doi: 10.1159/000089679. Epub 2005 Nov 9. Oncology. 2005. PMID: 16282709 Clinical Trial.

4

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC).

Giorgio CG, Pappalardo A, Russo A, Giuffrida D, Santini D, Petralia G, Castorina S, Nunzio R, Failla G, Bordonaro R. Giorgio CG, et al. Among authors: russo a. Lung Cancer. 2006 Mar;51(3):357-62. doi: 10.1016/j.lungcan.2005.10.023. Epub 2006 Jan 9. Lung Cancer. 2006. PMID: 16406602 Clinical Trial.

5

Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

Gargano G, Agnese V, Calò V, Corsale S, Augello C, Bruno L, La Paglia L, Gullo A, Ottini L, Russo A, Fulfaro F, Rinaldi G, Crosta A, Cicero G, Majorana O, Palmeri L, Cipolla C, Agrusa A, Gulotta G, Morello V, Di Fede G, Adamo V, Colucci G, Tomasino RM, Valerio MR, Bazan V, Russo A; Gruppo Oncologico dell'Italia Meridionale. Gargano G, et al. Among authors: russo a. Ann Oncol. 2006 Jun;17 Suppl 7:vii41-5. doi: 10.1093/annonc/mdl948. Ann Oncol. 2006. PMID: 16760290 Free article.

6

Reelin expression in human prostate cancer: a marker of tumor aggressiveness based on correlation with grade.

Perrone G, Vincenzi B, Zagami M, Santini D, Panteri R, Flammia G, Verzì A, Lepanto D, Morini S, Russo A, Bazan V, Tomasino RM, Morello V, Tonini G, Rabitti C. Perrone G, et al. Among authors: russo a. Mod Pathol. 2007 Mar;20(3):344-51. doi: 10.1038/modpathol.3800743. Epub 2007 Feb 2. Mod Pathol. 2007. PMID: 17277764 Free article.

7

Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan.

Vincenzi B, Santini D, Russo A, Gavasci M, Battistoni F, Dicuonzo G, Rocci L, Rosaria VM, Gebbia N, Tonini G. Vincenzi B, et al. Among authors: russo a. Pharmacogenomics. 2007 Apr;8(4):319-27. doi: 10.2217/14622416.8.4.319. Pharmacogenomics. 2007. PMID: 17391070 Clinical Trial.

8

A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.

Giorgio CG, Pappalardo A, Russo A, Santini D, Di Rosa C, Di Salvo C, Castorina S, Marletta F, Bellissima G, Palermo N, Scuderi C, Bordonaro R. Giorgio CG, et al. Among authors: russo a. Anticancer Drugs. 2007 Jul;18(6):713-9. doi: 10.1097/CAD.0b013e328082558a. Anticancer Drugs. 2007. PMID: 17762402 Free article. Clinical Trial.

9

Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence.

Russo A, Fratto ME, Bazan V, Schiró V, Agnese V, Cicero G, Vincenzi B, Tonini G, Santini D. Russo A, et al. Expert Opin Ther Targets. 2007 Dec;11(12):1571-86. doi: 10.1517/14728222.11.12.1571. Expert Opin Ther Targets. 2007. PMID: 18020979 Review.

10

Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?

Russo A, Calò V, Bruno L, Schirò V, Agnese V, Cascio S, Foddai E, Fanale D, Rizzo S, Di Gaudio F, Gulotta E, Surmacz E, Di Fede G, Bazan V. Russo A, et al. Breast Cancer Res Treat. 2009 Jan;113(1):67-70. doi: 10.1007/s10549-008-9906-7. Epub 2008 Jan 29. Breast Cancer Res Treat. 2009. PMID: 18228134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,593 results

Search Page

Filters